Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**AXIL is not a unique drug identifier.** Public sources use the brand name \"Axil\" for different active ingredients in different markets, including **pidotimod**, an oral synthetic immunomodulatory dipeptide used in respiratory and urinary tract infection settings, and **aceclofenac**, an oral nonsteroidal anti-inflammatory drug used for pain and inflammation. Because these are chemically and pharmacologically distinct medicines, AXIL cannot be safely normalized to one canonical drug entity without market, manufacturer, dosage form, or active-ingredient context. ([torrinomedica.it](https://www.torrinomedica.it/schede-farmaci/Axil/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AXIL.